IP Library Granted Patent US 12,721,685
Granted Patent B2
US 12,721,685 · App. 19/071,353 · Granted Sep 1, 2026

Use of evoked potentials in deep brain stimulation neuromodulation

Inventors: G. Karl Steinke (Valencia, CA); Mahsa Malekmohammadi (Sherman Oaks, CA)
Assignee: Boston Scientific Neuromodulation Corporation
A61B34/20A61B34/25A61N1/0534A61N1/08A61N1/36135A61N1/37241A61B2034/2053
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,685
App. No.
19/071,353
Granted
Sep 1, 2026
Kind
B2
Abstract

Methods and systems for providing deep brain stimulation (DBS) for a patient are described. Electrical stimulation is provided to a patient's brain and evoked potentials (EPs) are recorded at two or more electrodes. The EPs evoked and/or recorded at different electrodes are used to estimate if the respective electrodes are located in the same or different anatomical brain regions. The EPs may also be used to predict or suggest appropriate stimulation rates for therapeutic stimulation.

Claims (33)

1 . A method of estimating a position of an electrode lead within a patient's brain, wherein the electrode lead comprises a plurality of electrodes, the method comprising:

using one or more of the plurality of electrodes to provide active stimulation to the patient's brain;

using at least a first of the plurality of electrodes to record first evoked potentials (EPs) evoked by the active stimulation and a second of the plurality of electrodes to record second EPs evoked by the active stimulation;

comparing the first EPs and the second EPs to determine a delay between the EPs wherein the delay is indicative a difference in a number or kind of synapses between a first neural circuit giving rise to the first EP and a second neural circuit giving rise to the second EP; and

using the comparison to estimate a location of the electrode lead within the patient's brain.

2 . The method of claim 1 , wherein the first and second EPs comprise evoked resonant neural responses (ERNA).

3 . The method of claim 1 , wherein estimating a location of the electrode lead within the patient's brain comprises determining if the first and second electrodes are in different anatomical brain structures.

4 . The method of claim 1 , further comprising taking an action based on the estimated location of the electrode lead within the patient's brain.

5 . The method of claim 4 , wherein the action comprises moving the electrode lead or suggesting a move of the electrode lead.

6 . The method of claim 4 , wherein the action comprises suggesting or optimizing an electrode configuration, wherein the electrode configuration comprises one or more of the plurality of electrodes assigned to deliver therapeutic stimulation.

7 . The method of claim 4 , wherein the action comprises updating a prior estimate of the electrode lead's location within the patient's brain.

8 . The system of claim 7 , wherein the first and second EPs comprise evoked resonant neural responses (ERNA).

9 . A system for estimating a position of an electrode lead within a patient's brain, wherein the electrode lead comprises a plurality of electrodes, the system comprising:

control circuitry configured to:

use one or more of the plurality of electrodes to provide active stimulation to the patient's brain;

use at least a first of the plurality of electrodes to record first evoked potentials (EPs) evoked by the active stimulation and a second of the plurality of electrodes to record second EPs evoked by the active stimulation;

compare the first EPs and the second EPs to determine a delay between the EPs wherein the delay is indicative a difference in a number or kind of synapses between a first neural circuit giving rise to the first EP and a second neural circuit giving rise to the second EP; and

use the comparison to estimate a location of the electrode lead within the patient's brain.

10 . The system of claim 9 , wherein the first and second EPs comprise evoked compound action potentials (ERNA).

11 . The system of claim 9 , wherein estimating a location of the electrode lead within the patient's brain comprises determining if the first and second electrodes are in different anatomical brain structures.

12 . The system of claim 9 , further configured to take an action based on the location of the electrode lead within the patient's brain.

13 . The system of claim 12 , wherein the action comprises moving the electrode lead or suggesting a move of the electrode lead.

14 . The system of claim 12 , wherein the action comprises suggesting or optimizing an electrode configuration, wherein the electrode configuration comprises one or more of the plurality of electrodes assigned to deliver therapeutic stimulation.

15 . The system of claim 12 , wherein the action comprises updating a prior estimate of the electrode lead's location within the patient's brain.

16 . The system of claim 15 , wherein the updating comprises adjusting a location of a graphical representation of the electrode lead with respect to one or more graphical representations of imaging data using a graphical user interface (GUI).

17 . A method of estimating a position of an electrode lead within a patient's brain, wherein the electrode lead comprises a plurality of electrodes, the method comprising:

using one or more of the plurality of electrodes to provide active stimulation to the patient's brain;

using at least a first of the plurality of electrodes to record first evoked potentials (EPs) evoked by the active stimulation and a second of the plurality of electrodes to record second EPs evoked by the active stimulation;

comparing the first EPs and the second EPs to determine if the first and second electrodes are concurrently in different anatomical brain structures; and

using the comparison to estimate a location of the electrode lead within the patient's brain.

18 . The method of claim 17 , further comprising suggesting a move of the electrode lead based on the estimated location of the electrode lead within the patient's brain.

19 . The method of claim 17 , further comprising suggesting or optimizing an electrode configuration, wherein the electrode configuration comprises one or more of the plurality of electrodes assigned to deliver therapeutic stimulation based on the estimated location of the electrode lead within the patient's brain.

20 . The method of claim 17 , further comprising updating a prior estimate of the electrode lead's location within the patient's brain based on the estimated location of the electrode lead within the patient's brain.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2025
From: STEINKE, G. KARL; MALEKMOHAMMADI, MAHSA
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 070414/0704 →
Continuity (2)
Provisional Application 63570457 · Mar 27, 2024
Related Publication 20250302544A1 · Oct 2, 2025
References Cited (29)
US 6181969B1 · Gord · 2001 [cited by applicant]
US 6845267B2 · Harrison et al. · 2005 [cited by applicant]
US 6950707B2 · Whitehurst · 2005 [cited by applicant]
US 8606362B2 · He et al. · 2013 [cited by applicant]
US 8620436B2 · Parramon et al. · 2013 [cited by applicant]
US 11298070B2 · Sinclair et al. · 2022 [cited by applicant]
US 11813458B2 · Esteller et al. · 2023 [cited by applicant]
US 20120092031A1 · Shi et al. · 2012 [cited by applicant]
US 20120095519A1 · Parramon et al. · 2012 [cited by applicant]
US 20120095529A1 · Parramon et al. · 2012 [cited by applicant]
US 20130289665A1 · Marnfeldt et al. · 2013 [cited by applicant]
US 20150080982A1 · Funderburk · 2015 [cited by applicant]
US 20150157861A1 · Aghassian · 2015 [cited by applicant]
US 20150231402A1 · Aghassian · 2015 [cited by applicant]
US 20150360038A1 · Zottola et al. · 2015 [cited by applicant]
US 20180071513A1 · Weiss et al. · 2018 [cited by applicant]
US 20180071520A1 · Weerakoon et al. · 2018 [cited by applicant]
US 20180071527A1 · Feldman et al. · 2018 [cited by applicant]
US 20180140831A1 · Feldman et al. · 2018 [cited by applicant]
US 20180221644A1 · Grill et al. · 2018 [cited by applicant]
US 20190083796A1 · Weerakoon et al. · 2019 [cited by applicant]
US 20190209851A1 · Kothandaraman et al. · 2019 [cited by applicant]
US 20220040486A1 · Moffitt · 2022 [cited by applicant]
US 20220047872A1 · Ince et al. · 2022 [cited by applicant]
US 20220111213A1 · Cassar et al. · 2022 [cited by applicant]
US 20220296892A1 · Esteller · 2022 [cited by examiner]
US 20230099390A1 · Esteller et al. · 2023 [cited by applicant]
US 20230166111A1 · Hageman et al. · 2023 [cited by applicant]
International Search Report and Written Opinion Regarding Corresponding PCT Application No. PCT/US2025/018554, mailed May 13, 2025. [cited by applicant]